Skip to main content
CStone Pharmaceuticals logo

CStone Pharmaceuticals — Investor Relations & Filings

Ticker · 2616 ISIN · KYG2588M1006 LEI · 300300095A57F80T2461 HKEX Manufacturing
Filings indexed 3,378 across all filing types
Latest filing 2019-07-29 Report Publication Anno…
Country KY Cayman Islands
Listing HKEX 2616

About CStone Pharmaceuticals

http://www.cstonepharma.com

CStone Pharmaceuticals is an innovation-driven biopharmaceutical company focused on the research, development, and commercialization of anti-tumor drugs. The company is dedicated to addressing the unmet medical needs of cancer patients globally. Its core therapeutic focus is on innovative immuno-oncology and molecularly targeted therapies. The R&D pipeline is strategically balanced, featuring potential first-in-class or best-in-class assets, including Antibody-Drug Conjugates (ADC) and multi-specific antibodies. CStone has successfully launched four innovative drugs and secured multiple New Drug Application and indication approvals.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 95% confidence The document is extremely short (285 characters) and serves as a notification that an announcement has been published elsewhere on the website. It does not contain financial data, meeting details, or specific corporate actions, but rather acts as a pointer to another filing. Per the 'Menu vs Meal' rule, this is a notification of a publication rather than the report itself, fitting the definition of a Report Publication Announcement.
2019-07-29 English
ANNOUNCEMENT ON THE UNAUDITED MAJOR OPERATIONAL DATA OF THE SECONDQUARTER OF 2019
Regulatory Filings Classification · 90% confidence The document is an announcement from Yanzhou Coal Mining Company Limited regarding unaudited major operational data for the second quarter of 2019. It contains production and sales volume data for coal and coal chemicals but explicitly states the data is unaudited and subject to change. The document is relatively short (3350 characters) and is presented as an announcement rather than a full financial report. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR). Instead, it provides operational data updates voluntarily. This fits best with a Capital/Financing Update (CAP) or Regulatory Filings (RNS) category. However, since it is a voluntary announcement of operational data without direct financing or capital structure changes, and given the fallback nature of such announcements, the best classification is Regulatory Filings (RNS).
2019-07-29 English
VOLUNTARY ANNOUNCEMENT - CSTONE RECEIVES APPROVAL IN CHINA TO INITIATE IVOSIDENIB PHASE I BRIDGING REGISTRATIONAL STUDY FOR THE TREATMENT OF IDH1 MUTANT RELAPSED OR REFRACTORY AML
Regulatory Filings Classification · 95% confidence The document is a voluntary announcement by CStone Pharmaceuticals regarding the approval to initiate a Phase I bridging registrational study for a drug treatment in China. It contains detailed information about the drug, its indications, safety information, adverse reactions, and company background. There are no financial statements, quarterly or annual results, or regulatory certifications. The document is not a report but an announcement of a clinical trial approval and related drug information. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Regulatory Filings. It is a corporate announcement about a clinical trial approval and drug information, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2019-07-22 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2018
Environmental & Social Information Classification · 100% confidence The document is titled '2018 Environmental, Social and Governance Report' and contains detailed sections on environmental, social, and governance topics such as corporate social responsibility strategy, environmental performance, and social initiatives. It explicitly states it is an ESG Report prepared according to the ESG Reporting Guide from the Hong Kong Stock Exchange. The content focuses on non-financial performance related to sustainability and corporate responsibility rather than financial results or management changes. Therefore, this document fits the category of Environmental & Social Information (SR). The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or summary.
2019-07-16 English
PUBLICATION OF THE PRODUCTION AND SALES VOLUME FOR THE SECOND QUARTER OF 2019 OF AN OVERSEAS SUBSIDIARY CONTROLLED BY YANZHOU COAL MINING COMPANY LIMITED
Regulatory Filings Classification · 95% confidence The document is a short announcement from Yanzhou Coal Mining Company Limited regarding the production and sales volume for the second quarter of 2019 of an overseas subsidiary, Yancoal Australia. It provides summary data for production and sales volumes but does not contain detailed financial statements or comprehensive analysis. It also directs readers to the full reports published by Yancoal Australia on the ASX and HKEX websites for further details. The document length is only 2466 characters, which is quite short and consistent with an announcement rather than a full report. The text explicitly states it is a "voluntary announcement" and provides summary operational data rather than full financial results or management discussion. Therefore, this document is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories and are not full reports themselves.
2019-07-16 English
ANNOUNCEMENT ON RESULTS OF THE ISSUANCE OF THE 2019 SECOND TRANCHE OF SUPER-SHORT-TERM BONDS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the results of the issuance of a tranche of super-short-term bonds by Yanzhou Coal Mining Company Limited. It provides details about the bond issuance such as amount, interest rate, term, and dates. The document is relatively short (2882 characters) and is clearly an announcement of a financing activity, not a full financial report or detailed analysis. It does not contain comprehensive financial statements or management discussion, nor is it a regulatory certification or voting result. The content fits the category of Capital/Financing Update, which covers updates on company fundraising and financing activities.
2019-07-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.